Press Releases

Home/Media Center/Press Releases
Press Releases2021-07-26T19:32:19+00:00
ThuApr 29th, 2021

Lantern Pharma’s Proprietary A.I. Platform for Precision Oncology Drug Development, RADR®, Surpasses 4.6 Billion Datapoints, Accelerating the Company’s Progress in the Development of Biopharma Collaborations and Partnerships and Advancing the Company’s Strategy to Develop the World’s Largest A.I. Platform for Oncology-Focused Drug Development & Rescue

Lantern Pharma’s Proprietary A.I. Platform for Precision Oncology Drug [...]

Let’s start a conversation about the future of cancer drug development.

We are a biotech pharma at the intersection of Artificial Intelligence, genomics, and oncology drug development.

Contact Us